NCCN Patient Webinar: Myeloproliferative Neoplasms (MPN) скачать в хорошем качестве

NCCN Patient Webinar: Myeloproliferative Neoplasms (MPN)

Join experts as they provide information and answer questions about myeloproliferative neoplasms (MPN) to help patients and caregivers compare, discuss, and select treatment options with their doctor. See list below for topics discussed. Please note that this is a not an accredited activity. Topics Discussed: 00:00 - Welcome and Introductions 02:24 - Myeloproliferative Neoplasms (MPN) Disease Overview and Diagnosis 07:50 - Team Approach to Care 10:18 - What to Expect After MPN Diagnosis 14:50 - PV and ET: Initial Treatment and Watchful Waiting 24:03 - General Considerations of Managing MPN Patients 25:13 - Symptom Assessment 26:06 - Outlook of PV and ET 27:33 - Symptom Management and Healthy Living 32:02 - Myelofibrosis 41:31 - When to Consult with an MPN Specialist 45:45 - Financial Assistance 48:28 - How to Be Your Best Advocate 53:29 - Question & Answer Session 1:07:48 - Closing Remarks Question & Answer Session 53:38 - Should iron levels be part of testing along with complete blood counts (CBC)? 55:12 - Since the FDA approved Ropeginterferon for PV treatment, would it be considered a first line therapy? 56:08 - Should Ropeginterferon be used for young, lower risk patients? 58:36 - Is there a risk of over hydration having a result on your CBC? 59:48 - Is there more specific testing for prognosis? 1:02:10 - Long term risks for being on hydroxyurea? 1:04:29 - Does the treatment of a younger adult different than an older adult? 1:05:59 - What are the next steps for a person diagnosed with triple negative ET? The Patient Webinar: Myeloproliferative Neoplasms (MPN) occurred in April 2022. This informational program was created in conjunction with the recently updated NCCN Guidelines for Patients® for Myeloproliferative Neoplasms. https://www.nccn.org/patientresources...) The NCCN Guidelines for Patients (http://nccn.org/patientguidelines) are available to read and download for free online and via the NCCN Patient Guides for Cancer mobile app. Printed editions can be ordered from Amazon.com for a small fee. NCCN Guidelines for Patients DO NOT replace the expertise and clinical judgment of the clinician. Supporters: This webinar is supported through the NCCN Foundation and by contributions from our corporate supporters: AbbVie; Bristol Myers Squibb; and Incyte Corporation. ________________________________________________________________ About NCCN Foundation®: NCCN FOUNDATION® is a 501(c)3 organization founded by the National Comprehensive Cancer Network® (NCCN®)—a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education—to empower people living with cancer and advance oncology innovation. For more information or to make a donation, visit http://www.nccn.org/patients/foundation ________________________________________________________________ About NCCN: The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so all patients can live better lives. Visit https://www.nccn.org/ for more information. Subscribe to our channel for the latest in cancer care: https://www.youtube.com/c/NCCNvideo?s... Connect with us! Twitter:   / nccn   LinkedIn:   / nccn   Facebook:   / nccnorg   Instagram:   / nccnorg